Generate Biomedicines, Inc. Common Stock GENB
$14.46
-8.31%
at last close
Recent SEC Filings
| Form | Description | Filed | Document |
|---|---|---|---|
| 4 | 4 | 2026-09-03 | View → |
| 8-K | 8-K | 2026-08-26 | View → |
| 10-Q | 10-Q | 2026-08-06 | View → |
| 8-K | 8-K | 2026-08-06 | View → |
| 10-Q | 10-Q | 2026-05-07 | View → |
| 8-K | 8-K | 2026-05-07 | View → |
| 4 | 4 | 2026-03-06 | View → |
| 4 | 4 | 2026-03-02 | View → |
| 4 | 4 | 2026-03-02 | View → |
| 4 | 4 | 2026-03-02 | View → |
| 4 | 4 | 2026-03-02 | View → |
| 4 | 4 | 2026-03-02 | View → |
| 4 | 4 | 2026-03-02 | View → |
| 4 | 4 | 2026-03-02 | View → |
| 4 | 4 | 2026-03-02 | View → |
| 4 | 4 | 2026-03-02 | View → |
| 4 | 4 | 2026-03-02 | View → |
| 4 | 4 | 2026-03-02 | View → |
| 4 | 4 | 2026-03-02 | View → |
| 4 | 4 | 2026-03-02 | View → |
| 4 | 4 | 2026-03-02 | View → |
| 4 | 4 | 2026-03-02 | View → |
| 8-K | 8-K | 2026-03-02 | View → |
| S-1 | S-1 | 2026-02-04 | View → |
Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.
Key Stats
- Last Close
- $14.46
- Market Cap
- $1.86 billion
- 52-Week Range
- $11.00 – $22.67
- Average Volume
- 1.11 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.